• 17722 Citations
  • 63 h-Index
1992 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Zhimin Shao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
China Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2020

IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability

Zhang, L., Qiang, J., Yang, X., Wang, D., Rehman, A. U., He, X., Chen, W., Sheng, D., Zhou, L., Jiang, Y. Z., Li, T., Du, Y., Feng, J., Hu, X., Zhang, J., Hu, X. C., Shao, Z. M. & Liu, S., Jan 1 2020, In : Advanced Science. 7, 1, 1901728.

Research output: Contribution to journalArticle

Open Access
Interleukin-1 Type II Receptors
interleukins
progressions
breast
Tumors

Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems

Jin, M. L., Gong, Y., Pei, Y. C., Ji, P., Hu, X. & Shao, Z. M., Feb 2020, In : Breast. 49, p. 93-100 8 p.

Research output: Contribution to journalArticle

Open Access
Lymph Nodes
Breast Neoplasms
Proportional Hazards Models
Epidemiology

A nomogram predicting lymph node metastasis in t1 breast cancer based on the surveillance, epidemiology, and end results program

Zhao, Y. X., Liu, Y. R., Xie, S., Jiang, Y. Z. & Shao, Z. M., Jan 1 2019, In : Journal of Cancer. 10, 11, p. 2443-2449 7 p.

Research output: Contribution to journalArticle

Open Access
SEER Program
Nomograms
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
1 Citation (Scopus)

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology

Zhang, X., Liang, Z., Wang, S., Lu, S., Song, Y., Cheng, Y., Ying, J., Liu, W., Hou, Y., Li, Y., Liu, Y., Hou, J., Liu, X., Shao, J., Tai, Y., Wang, Z., Fu, L., Li, H., Zhou, X., Bai, H. & 31 others, Wang, M., Lu, Y., Yang, J., Zhong, W., Zhou, Q., Yang, X., Wang, J., Huang, C., Liu, X., Zhou, X., Zhang, S., Tian, H., Chen, Y., Ren, R., Liao, N., Wu, C., Zhu, Z., Pan, H., Gu, Y., Wang, L., Liu, Y., Zhang, S., Liu, T., Chen, G., Shao, Z., Xu, B., Zhang, Q., Xu, R., Shen, L., Wu, Y. & On behalf of Chinese Society of Clinical Oncology (CSCO) Tumor Biomarker Committee, B. O. C. S. O. C. O. CSCO. T. B. C., Jan 1 2019, In : Cancer Biology and Medicine. 16, 1, p. 189-204 16 p.

Research output: Contribution to journalArticle

Open Access
Precision Medicine
Medical Oncology
Tumor Biomarkers
Joints
Technology
1 Citation (Scopus)

CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50

Chi, Y., Xue, J., Huang, S., Xiu, B., Su, Y., Wang, W., Guo, R., Wang, L., Li, L., Shao, Z., Jin, W., Wu, Z. & Wu, J., Jan 1 2019, In : Theranostics. 9, 23, p. 6840-6855 16 p.

Research output: Contribution to journalArticle

Open Access
Paclitaxel
Transcriptional Activation
Breast Neoplasms
Phosphatidylinositol 3-Kinases
Drug Therapy